The Greater Cannabis Company Announces Distribution Agreement With Leading Global Cannabis Company iCAN: Israel Cannabis Ltd. globenewswire.com/news-release/2…

The Greater Cannabis Company Announces Uplisting To New Market Tier globenewswire.com/news-release/2…

GREATER CANNABIS TO BEGIN CLINICAL STUDY OF CBD ABSORPTION THROUGH ITS MULTIFUNCTIONAL, MULTILAYER INTRA-ORAL DRUG DELIVERY TECHNOLOGY globenewswire.com/news-release/2…

Greater Cannabis Company Announces Expansion Into CBD Cosmetics And Beauty Market globenewswire.com/news-release/2…

Greater Cannabis Company Partners with Allume Cosmeticos To Develop New Cosmetics Line globenewswire.com/news-release/2…

GREATER CANNABIS COMPANY LICENSES CBD PATCH TECHNOLOGY TO MAJOR BRAZILIAN RETAIL PHARMACY COMPANY globenewswire.com/news-release/2…

Going on live with “Between Bells” on Cheddar to discuss GCANRx’s innovative cannabis delivery patch.

Enjoyed being on Between Bells with Kristen Scholer and Baker Machado on Cheddar. Great show! cheddar.com/media/gcanrx-o…

Was great to be on your show today to discuss the vaping problem and GCANRx's solution. Thanks Adam Shapiro , Julie Hyman and the rest of the On The Move team Yahoo Finance

GCANRx offers oral patch with cannabinoid, as vaping-related illnesses increase finance.yahoo.com/video/gcanrx-o… via Yahoo Finance

GCANRx Signs Licensing Agreement with Shaare Zedek Scientific for Innovative Cannabinoid Therapy. Novel therapeutic focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease and other neuropsychiatric disorders. finance.yahoo.com/news/gcanrx-si…

GCANRx has begun the preclinical phase of assessing its novel neuropsychiatric cannabinoid therapy. The Company expects the study to generate in vitro data that will demonstrate significant neuroprotective attributes of the therapeutic. finance.yahoo.com/news/gcanrx-an…

We are excited to welcome Dr. Adi Aran, M.D. as strategic advisor! Dr. Aran will be advancing our clinical study program and expansion of our therapeutic pipeline. finance.yahoo.com/news/gcanrx-ap…

GCANRx's Strategic Advisor and Therapeutic Inventor Dr. Adi Aran, M.D. to be Interviewed by Dr. Sanjay Gupta on CNN Cannabis Special Sunday, December 19th at 9pm ET

We are exited to announce that we have received final approval to begin a Phase II Clinical Study of our proprietary therapeutic on Autism Spectrum Disorder. Further updates will be forthcoming. biospace.com/article/releas…

GCANRx featured in the American Journal of Endocannabinoid Medicine. The feature discusses the autism-cannabis connection and the mounting evidence of the therapeutic benefits of medical cannabis on neuropsychiatric disorders. endocannabinoidmedicine.com/features/israe…

We're proud to announce another milestone for our cannabinoid based therapeutic! globenewswire.com/news-release/2…

globenewswire.com/news-release/2…

finance.yahoo.com/news/gcanrx-an…